@article{a4f513be9e4244d89f45e388ef44ffdc,
title = "Costs and financial feasibility of malaria elimination",
abstract = "The marginal costs and benefits of converting malaria programmes from a control to an elimination goal are central to strategic decisions, but empirical evidence is scarce. We present a conceptual framework to assess the economics of elimination and analyse a central component of that framework - potential short-term to medium-term financial savings. After a review that showed a dearth of existing evidence, the net present value of elimination in five sites was calculated and compared with effective control. The probability that elimination would be cost-saving over 50 years ranged from 0 to 42, with only one site achieving cost-savings in the base case. These findings show that financial savings should not be a primary rationale for elimination, but that elimination might still be a worthy investment if total benefits are sufficient to outweigh marginal costs. Robust research into these elimination benefits is urgently needed.",
author = "Oliver Sabot and Cohen, {Justin M.} and Hsiang, {Michelle S.} and Kahn, {James G.} and Suprotik Basu and Linhua Tang and Bin Zheng and Qi Gao and Linda Zou and Allison Tatarsky and Shahina Aboobakar and Jennifer Usas and Scott Barrett and Cohen, {Jessica L.} and Jamison, {Dean T.} and Feachem, {Richard G A}",
note = "Funding Information: We thank the many other individuals who contributed to this work, particularly Simon Kunene, Abdullah Ali, and the members of the Swaziland and Zanzibar National Malaria Control Programmes for their inspiring analysis and pursuit of malaria elimination; Colin Boyle, Chris Cotter, Clara Kim, Angela Ni, Yuan Sun, Mitsuru Toda, Shanqing Wang, and Huayun Zhou for their invaluable contributions. The work of the Global Health Group of the University of California, San Francisco, on malaria elimination is supported by grants from the Bill & Melinda Gates Foundation and ExxonMobil. The Clinton Health Access Initiative acknowledges support from the Global Health Group for their work on malaria elimination in southern Africa. We are also grateful for the financial support from the Bill & Melinda Gates Foundation to the Clinton Health Access Initiative and the Institute of Health Metrics and Evaluation, University of Washington. JGK was supported in part by NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131 . Lastly, we are grateful to members of the Malaria Elimination Group for their guidance on the material in this paper. ",
year = "2010",
month = nov,
day = "6",
doi = "10.1016/S0140-6736(10)61355-4",
language = "English (US)",
volume = "376",
pages = "1604--1615",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9752",
}